Ticker Scorecard - AQST Basics Company: Aquestive Therapeutics, Inc. IPO Date: July 23, 2018 Sector: Healthcare Industry: Drug Manufacturers - Specialty and Generic Market Cap: $263.5M Activated in VL: True Average Daily Range Avg Daily Range: $0.16 | 3.75% Avg Daily Range (30 D): $0.09 | 2.81% Avg Daily Range (90 D): $0.13 | 2.93% Institutional Daily Volume Avg Daily Volume: .66M Avg Daily Volume (30 D): 1.26M Avg Daily Volume (90 D): 1.33M Trade Size Avg Trade Size (Sh.): 183 Avg Trade Size (Sh.) (30 D): 164 Avg Trade Size (Sh.) (90 D): 148 Institutional Trades Total Inst.Trades: 107 Avg Inst. Trade: $1.77M Avg Inst. Trade (30 D): $1.21M Avg Inst. Trade (90 D): $1.28M Avg Inst. Trade Volume: .42M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.34M Avg Closing Trade (30 D): $1.62M Avg Closing Trade (90 D): $1.35M Avg Closing Volume: 541.38K     News Jun 27, 2024 @ 12:00 PM Aquestive Therapeutics to Participate in Leerink P... Source: Aquestive Therapeutics, Inc. Jun 3, 2024 @ 12:00 PM Aquestive Therapeutics Announces Executive Appoint... Source: Aquestive Therapeutics, Inc. May 24, 2024 @ 12:59 PM 5 Small Drug Stocks to Buy From a Recovering Indus... Source: Kinjel Shah May 9, 2024 @ 12:00 PM Aquestive Therapeutics to Participate in The Citiz... Source: Aquestive Therapeutics, Inc. May 7, 2024 @ 11:00 PM Compared to Estimates, Aquestive Therapeutics (AQS... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.45 $-.13 $-.03 Diluted EPS $-.45 $-.13 $-.03 Revenue $ 58.9M $ 13.54M $ 20.1M Gross Profit $ 40.87M $ 9.11M $ 15.57M Net Income / Loss $ -35.19M $ -11.51M $ -2.75M Operating Income / Loss $ -21.1M $ -8.29M $ .06M Cost of Revenue $ 18.03M $ 4.44M $ 4.53M Net Cash Flow $ 52.98M $ -11.98M $ -5.33M PE Ratio